MAIN MENU
QUICK LINKS
CONNECT WITH US

Button

Clinical Trial Details

Title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of RA101495 in Subjects with Generalized Myasthenia Gravis
Study Description

The main purpose of this study is to test the effectiveness of RA101495 for the treatment of patients with gMG.

Investigators

Principal Investigator
Michael T. Pulley, M.D., Ph.D.
Neurology

Sub Investigator
Alan R. Berger, M.D.
Neurology